MarkNtel Advisors recently published a detailed industry analysis of the India Cancer Treatment Drugs Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
India Cancer Treatment Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030
The India Cancer Treatment Drugs Market is projected to grow at a CAGR of around 12.2% during the forecast period, i.e., 2025-30.
What are the major Driver the India Cancer Treatment Drugs industry?
Numerous Schemes Encouraging Affordable & Effective Cancer Diagnosis &Treatment – Cancer treatment has been one of the main focal areas of the Pradhan Mantri Jan Arogya Yojana in order to protect the beneficiaries from the catastrophic costs of cancer treatment. The delivery of services under the Ayushman Bharat Health and Wellness Centers (AB-HWCs) includes screening for three common malignancies, including oral, breast, and cervical cancers and other common non-communicable diseases.
Along similar lines, The National Pharmaceutical Pricing Authority (NPPA), which is part of the Ministry of Chemicals and Fertilizers, released a list of 390 non-scheduled anti-cancer medications in 2019 with MRP reductions of up to 87%. This action helped 22 lakh cancer patients in the nation and would save consumers about Rs. 800 crores annually. Following a decade of caution and organic growth, Indian pharmaceutical businesses are currently on an acquisition binge. And cancer medications seem to be their primary focus, thus driving the drug industry in the long run.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/india-cancer-treatment-market.html
What segments define the India Cancer Treatment Drugs market from 2025 to 2030? How do these segments contribute to market dynamics and growth?
- By Treatment Type
-
-
- Chemotherapy- Market Size & Forecast 2020-2030, USD Million
- Targeted Therapy- Market Size & Forecast 2020-2030, USD Million
- Immunotherapy- Market Size & Forecast 2020-2030, USD Million
- Hormonal Therapy- Market Size & Forecast 2020-2030, USD Million
- Other Treatment Types- Market Size & Forecast 2020-2030, USD Million
-
According to report, the Targeted Therapy segment acquired the largest share of the India Cancer Treatment Drugs Market during the historical period
- By Drug Class
- Cytotoxic Drugs- Market Size & Forecast 2020-2030, USD Million
- Alkylating Agents- Market Size & Forecast 2020-2030, USD Million
- Antimetabolites- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Targeted Drugs- Market Size & Forecast 2020-2030, USD Million
- Monoclonal Antibodies- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Hormonal Drugs- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Cytotoxic Drugs- Market Size & Forecast 2020-2030, USD Million
According to report, the majority of highest-priority medicines were conventional cytotoxic therapy.
- By Type
- Blood Cancer- Market Size & Forecast 2020-2030, USD Million
- Breast Cancer- Market Size & Forecast 2020-2030, USD Million
- Colorectal Cancer- Market Size & Forecast 2020-2030, USD Million
- Cervical Cancer- Market Size & Forecast 2020-2030, USD Million
- Prostate Cancer- Market Size & Forecast 2020-2030, USD Million
- Gastrointestinal Cancer- Market Size & Forecast 2020-2030, USD Million
- Gynecologic Cancer- Market Size & Forecast 2020-2030, USD Million
- Non-Hodgkin’s Cancer- Market Size & Forecast 2020-2030, USD Million
- Respiratory/ Lung Cancer- Market Size & Forecast 2020-2030, USD Million
- Stomach Cancer- Market Size & Forecast 2020-2030, USD Million
- Other Cancers- Market Size & Forecast 2020-2030, USD Million
- By Dosage Form
- Solid- Market Size & Forecast 2020-2030, USD Million
- Tablets- Market Size & Forecast 2020-2030, USD Million
- Capsules- Market Size & Forecast 2020-2030, USD Million
- Liquid- Market Size & Forecast 2020-2030, USD Million
- Injectable- Market Size & Forecast 2020-2030, USD Million
- Prefilled Syringes- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Solid- Market Size & Forecast 2020-2030, USD Million
Explore the Complete India Cancer Treatment Drugs Market Analysis Report – https://www.marknteladvisors.com/research-library/india-cancer-treatment-market.html
- By End-Users
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
- Cancer and Radiation Therapy Centers- Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel
- Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
Geographical Analysis: India Cancer Treatment Drugs Market
-
- North
- South
- East
- West
India Cancer Treatment Drugs Market Share & Competitive Landscape:
The India Cancer Treatment Drugs Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry’s leading companies, highlighting their strengths, financial performance, and market influence.
Leading Companies in the India Cancer Treatment Drugs Market are:
- Amgen
- Astellas Pharma Inc.
- AstraZeneca
- Bayer
- Bristol-Myers Squibb Company
- Cipla
- Hoffmann- La- Roche
- Merck KGaA
- Natco Pharma
- Novartis AG and Others
India Cancer Treatment Drugs Industry Recent Development:
- In August 2022, AstraZeneca India, a pharmaceutical company, announced that the Drugs Controller General of India had given the go-ahead to commercialize its medication for breast cancer treatment, Lynparza (Olaparib), as a monotherapy. Lynparza is the first and only approved medicine targeting BRCA (Breast Cancer gene) mutations in early-stage breast cancer.
- In June 2022, For the first time in history, a small clinical trial done by Memorial Sloan Kettering Cancer Center discovered that Dostarlimab, a medicine made in a lab that functions as a surrogate for antibodies in the human body, has the potential to be a ‘possible’ cancer cure for one of the most lethal tumors.
Questions Addressed in this Study
1.What factors are driving the India Cancer Treatment Drugs Market growth?
2.How is the India Cancer Treatment Drugs Market expected to grow over the next five years?
3.What are the key insights into the current trends in the India Cancer Treatment Drugs Market?
4.What is the current size of the India Cancer Treatment Drugs Market, and how is it projected to change in the future?
6.What is the future outlook for the India Cancer Treatment Drugs Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/india-cancer-treatment-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Others Reports:
More Research Studies Report:
–Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.
–Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
